Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This year tags : Genetown save search
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
ENTA | News | $14.005 -8.82% -9.68% 190K
|
Health Technology
|
| O: -4.2%
H: 0.0%
C: 0.0%
presentation pharmaceuticals global
SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
AGEN | News | $5.385 -14.52% -16.99% 1.5M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
qs-21 cell for agreement
Vizgen Issued a New US Patent for Its MERFISH Technology
Published: 2024-04-16 (Crawled : 18:00) - biospace.com/
TXG | $29.12 -5.46% -5.77% 2.9M
|
Health Technology
|
| O: -2.62%
H: 0.57%
C: -3.75%
patent for technology
VBI Vaccines Reports Full Year 2023 Financial Results
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VBIV | $0.591 -4.68% -4.91% 370K
|
Health Technology
|
| O: -3.45%
H: 14.29%
C: 10.71%
year financial results
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BPMC | $88.395 2.68% 2.61% 730K
|
Health Technology
|
| O: 1.08%
H: 1.19%
C: 0.85%
conference for therapeutics
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
VSTM | $10.82 -1.01% -1.02% 54K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
medical therapeutics
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
CRL | $230.09 -0.97% 0.0% 500K
|
Commercial Services
|
| O: 0.48%
H: 0.0%
C: 0.0%
for
Black Diamond Therapeutics Announces Changes to Board of Directors - April 11, 2024
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BDTX A | $5.7 5.95% 5.61% 920K
|
Health Technology
|
| O: -3.01%
H: 11.9%
C: 11.4%
therapeutics
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BLUE | $0.9668 -2.37% -2.43% 8.7M
|
Health Technology
|
| O: 1.68%
H: 1.65%
C: -4.13%
nasdaq grants
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
DCPH | $14.72 -0.81% -0.82% 300K
|
Health Technology
|
| O: -2.13%
H: 5.02%
C: 4.69%
pharmaceuticals
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
MCRB | $0.6274 -1.37% -1.39% 4.8M
|
Health Technology
|
| O: -2.31%
H: 3.86%
C: -1.47%
ser-155 for trial therapeutics
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
SYRS | $5.105 -8.18% -8.91% 130K
|
Health Technology
|
| O: 2.16%
H: 23.21%
C: 16.03%
fda treatment designation for aml
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
OCUL | $7.58 -2.7% -2.77% 980K
|
Health Technology
|
| O: -9.56%
H: 2.44%
C: 2.25%
nasdaq ocular global grants
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
Published: 2024-04-08 (Crawled : 22:00) - biospace.com/
BPTS | $0.2905 -17.38% 45K
|
Manufacturing
|
| O: -3.31%
H: 0.0%
C: -4.69%
bio101 obesity study
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
AMLX | $1.99 -1.0% -1.01% 1.7M
|
|
| O: 1.15%
H: 7.92%
C: 1.51%
amx0035 pharmaceuticals study
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
ACET | $2.26 3.2% 3.1% 760K
|
Health Technology
|
| O: -1.33%
H: 1.8%
C: -1.8%
conference
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
CCCC | $6.89 0.88% 0.87% 1.2M
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 approved preclinical for therapeutics
BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
pipeline key platform
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 23:00) - biospace.com/
STOK | News | $11.75 -5.62% -5.96% 740K
|
Health Technology
|
| O: 1.83%
H: 6.44%
C: -6.74%
conference therapeutics
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
drug collaboration therapeutics
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.